Sent,Tm,Lex,Luhn,Lsa,Tr,LDA
"Bat spit drug firm goes to market

A German firm whose main product is derived from the saliva of the vampire bat is looking to raise more than 70m euros ($91m; Â£49m) on the stock market.

",27.6,0.12774189248283424,94,0.06784106667493885,0.1338788808277544,0.7732691428510292
"The firm, Paion, said that it hoped to sell 5 million shares - a third of the firm - for 11-14 euros a share.",14.72,0.14722108675192125,48,0.3033437710336108,0.1264689258730275,0.7548490095865137
"Its main drug, desmoteplase, is based on a protein in the bat's saliva.",13.8,0.18905767989776054,40,-0.16097164696440003,0.1096007350655631,0.730854976880901
"The protein stops blood from clotting - which helps the bat to drink from its victims, but could also be used to help stroke sufferers.",11.040000000000001,0.09490677197708719,56,-0.15416339279103156,0.10428765301650876,0.7508641671772677
"The company's shares go on sale later this week, and are scheduled to start trading on the Frankfurt Stock Exchange on 10 February.",5.5200000000000005,0.10438205859250937,71,0.24890687331303465,0.12032856855852139,0.7585063402121532
"If the final price is at the top of the range, the company could be valued at as much as 200m euros.",5.5200000000000005,0.1154623854332794,38,0.07171635537638406,0.12491431447311047,0.7321699837754256
"The money raised will be spent largely on developing the company's other drugs, since desmoteplase has already been licensed to one manufacturer, Forest Laboratories.
",7.36,0.10122812486460803,88,-0.10193506499776334,0.1205209221855144,0.757909497182966
